MedTech Stock Cooper Companies Poised For Organic Growth, Analysts Have Confidence In Stock
Portfolio Pulse from Vandana Singh
Cooper Companies (NYSE:COO) reported Q3 adjusted EPS of $3.35, slightly ahead of the consensus of $3.34, and Q3 sales of $930.20 million, up 10% Y/Y, beating the consensus of $899.75 million. The company sees FY24 adjusted EPS of $12.72-$12.90 compared to the consensus of $12.82, and revenue of $3.578-$3.595 billion versus the consensus of $3.55 billion. Analysts from William Blair and Needham expressed confidence in the company's potential for significant organic revenue growth.
August 31, 2023 | 6:19 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cooper Companies reported strong Q3 results and is expected to see significant organic revenue growth. However, its shares are currently fairly valued, leading to a Hold rating.
Cooper Companies reported strong Q3 results, beating consensus estimates, and is expected to see significant organic revenue growth. However, despite the positive outlook, the company's shares are currently considered fairly valued, leading analysts to give a Hold rating. This suggests that while the company's performance is strong, it may not necessarily lead to an immediate increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100